1-6 of 6
Deniz Sargin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adult Case Series of Extramedullary Relapsing Acute Myeloid Leukemia (AML) after Allogeneic Stem Cell Transplantation in Whom a Rapid Response and a Reasonably Long Remission Could be Achieved with Gemtuzumab Ozogamycin (GO)

Omur Gokmen Sevindik, MD, Ali Ihsan Gemici, Furkan Selim Usta, Asli Çakır, Sevil Sadri, MD, Hüseyin Beköz, Fatma Deniz Sargın
Journal: Blood
Blood (2019) 134 (Supplement_1): 5129.
https://doi.org/10.1182/blood-2019-126195
Published: 2019
Journal Articles

Prognostic Significance Of ASXL1 and IDH Mutations inPhiladelphia Negative Myeloproliferative Neoplasms

Ipek Yonal, Aynur Daglar Aday, Aysegul Basak Akadam, Ceylan Yilmaz, Meliha Nalcaci, Akif Selim Yavuz, Fatma Deniz Sargin
Journal: Blood
Blood (2013) 122 (21): 5260.
https://doi.org/10.1182/blood.V122.21.5260.5260
Published: 2013
Journal Articles

Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study

Meletios A. Dimopoulos, Hadewijch M De Samblanx, MD, Maria G Roussou, Konstantinos Zervas, Eirini Katodritou, Deniz Sargin, MD, Cyrille Hulin, MD, Lucia Ahlberg, MD, Javier De La Rubia, Rita Ganguly, PhD, Joris K Diels, MSc, Helgi van de Velde, MD, PhD, Ravinder Dhawan, PhD, Michael D Spencer, MSc, Michel Delforge, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3027.
https://doi.org/10.1182/blood.V116.21.3027.3027
Published: 2010
Journal Articles

Characterization of Patients with Multiple Myeloma Achieving Complete Response to Bortezomib: An Interim Report From An International Electronic Observational Study.

Michel Delforge, MD, PhD, Hadewijch De Samblanx, Maria Roussou, Konstantinos Zervas, Eirini Katodritou, Kudrat M Abdulkadyrov, Deniz Sargin, Cyrille Hulin, Lucia Ahlberg, Javier de la Rubia, Rita Ganguly, Joris Diels, Ravinder Dhawan, Meletios A. Dimopoulos
Journal: Blood
Blood (2009) 114 (22): 4938.
https://doi.org/10.1182/blood.V114.22.4938.4938
Published: 2009
Journal Articles

Response to Bortezomib Therapy for Multiple Myeloma (MM) in Actual Clinical Practice: Preliminary Effectiveness Findings of an International Observational Study.

Michel Delforge, MD, PhD, Eirini Katodritou, MD, PhD, Konstantinos Zervas, MD, PhD, Deniz Sargin, MD, Cyrille Hulin, MD, Mats Linderholm, MD, PhD, Evgenia Verrou, MD, Vicki Poon, MPH, Ravinder Dhawan, PhD
Journal: Blood
Blood (2007) 110 (11): 4837.
https://doi.org/10.1182/blood.V110.11.4837.4837
Published: 2007
Journal Articles

Does Previous Interferon Use Have Negative Effect on Imatinib Response in Chronic Myeloid Leukemia (CML)? A Single Center Study.

Mustafa Yenerel, Reyhan Diz-Kucukkaya, Naciye Demirel, Mesut Ayer, Selim Yavuz, Sevgi Besisik, Melih Aktan, Meliha Nalcaci, Deniz Sargin, Tanju Atamer, Yuksel Pekcelen, Guncag Dincol
Journal: Blood
Blood (2006) 108 (11): 4821.
https://doi.org/10.1182/blood.V108.11.4821.4821
Published: 2006